EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of highly potent HDAC8 PROTACs with anti-tumor activity

Chunlong Zhao, Deng Chen, Fengzhi Suo, Rita Setroikromo, Wim J Quax, Frank J Dekker

Bioorganic Chemistry · 2023-07 · 136 · 106546

DOI: 10.1016/j.bioorg.2023.106546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023-07. Verfasst von Chunlong Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, …. Hauptthemen laut MEDLINE: Repressor Proteins, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various diseases are deeply associated with aberrations in HDAC8 functions. These aberrations can be assigned to either structural functions or catalytic functions of HDAC8. Therefore, development of HDAC8 degradation inducers might be more promising than HDAC8 inhibitors. We employed the proteolysis targeting chimera (PROTAC) strategy to develop a selective and potent HDAC8 degradation inducer CT-4 with single-digit nanomolar DC50 values and over 95% Dmax in both triple-negative breast cancer MDA-MB-231 cells and T-cell leukemia cells. Notably, CT-4 demonstrated potent anti-migration activity and limited anti-proliferative activity in MDA-MB-231 cells. In contrast, CT-4 effectively induced apototic cell death in Jurkat cells, as assessed by a caspase 3/7 activity assay and flow cytometry. Our findings suggest that the development of HDAC8 degradation inducers holds great potential for the treatment of HDAC8-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Repressor ProteinsProteolysis Targeting ChimeraHumansCell Line, TumorHistone DeacetylasesJurkat CellsProteolysisHistone Deacetylase Inhibitors

Stichwörter der Autor:innen

ApoptosisHistone deacetylase 8 (HDAC8)MigrationProteolysis Targeting Chimeras (PROTACs)T-cell leukemiaTriple-Negative Breast Cancer (TNBC)

Substanzen

Repressor ProteinsProteolysis Targeting ChimeraHistone DeacetylasesHistone Deacetylase InhibitorsHDAC8 protein, human

Autor:innen und Institutionen

  • Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands.
  • Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713AV Groningen, The Netherlands. Electronic address: f.j.dekker@rug.…

Förderung

  • China Scholarship Council

Zitieren

APA

Zhao, C., Chen, D., Suo, F., Setroikromo, R., Quax, W. J., & Dekker, F. J. (2023). Discovery of highly potent HDAC8 PROTACs with anti-tumor activity. Bioorganic Chemistry, 136, 106546. https://doi.org/10.1016/j.bioorg.2023.106546

Vancouver

Zhao C, Chen D, Suo F, Setroikromo R, Quax WJ, Dekker FJ. Discovery of highly potent HDAC8 PROTACs with anti-tumor activity. Bioorganic Chemistry. 2023;136:106546. doi:10.1016/j.bioorg.2023.106546

BibTeX
@article{Zhao2023,
  author = {Zhao, Chunlong and Chen, Deng and Suo, Fengzhi and Setroikromo, Rita and Quax, Wim J and Dekker, Frank J},
  title = {Discovery of highly potent HDAC8 PROTACs with anti-tumor activity},
  journal = {Bioorganic Chemistry},
  year = {2023},
  volume = {136},
  pages = {106546},
  doi = {10.1016/j.bioorg.2023.106546}
}
Kostenlos starten →